The latest news in investment offerings, financial products and other services relevant to wealth advisors and their clients.

Polar Capital
Polar Capital announced late last week that it would be renaming its Healthcare Blue Chip Fund as the Polar Capital Global Healthcare Select Fund.

The name change is a better reflection of the fund’s long-standing, high-conviction investment approach and the breadth of opportunities it targets across the global healthcare sector, Polar Capital said.

The fund is a portfolio of 25 to 40 stocks, constructed through detailed bottom-up research. The portfolio has “meaningful exposure” to small and mid-cap healthcare companies alongside established global leaders, rather than being limited to the largest names in the index, Polar Capital said.

“This is not a change in investment strategy. The fund has always been managed as a focused, actively managed portfolio and we have full conviction in the investment proposition. The new name more accurately reflects how we invest and the types of opportunity we seek within the healthcare universe,” James Douglas, who manages the fund, said.

Polar Capital, which was founded in 2001, had a total of £30.6 billion ($41.39 billion) of assets under management as of 31 March. It is principally located in London, with offices in the UK, France, Spain, Germany, Switzerland, the US, China and Singapore. It is authorised and regulated by the UK Financial Conduct Authority and registered as an investment advisor with the US Securities and Exchange Commission.